Outcome of patients treated by intravitreal injections during the COVID-19 lockdown: An institutional experience
Description
CONCLUSION: COVID-19 lockdown did not seem to negatively affect the 1-year outcome of patients with retinal diseases treated by anti-VEGF IVIs who missed their scheduled injections. The BCVA and rate of complications at 1 year did not differ whether
